Heart failure reviewsHumansHeart FailurePyrimidinesStroke VolumeCyclic GMP
Victoria and Victor: event-driven lessons for integrating vericiguat into practice and reducing residual risk in HFrEF.
Kalliopi Keramida, Francesca Musella, Magdy Abdelhamid, Naoki Sato, Stephen J Greene, Dimitrios Farmakis, Josephine Harrrington, Andrew P Ambrosy
Published: 202510.1007/s10741-025-10587-y
Abstract
Chronic heart failure with reduced ejection fraction (HFrEF) is a progressive syndrome associated with substantial residual morbidity and mortality despite contemporary guideline-directed medical therapy (GDMT) - angiotensin-converting enzyme inhibit…
Preview only. Read the full abstract at the source